TMS: Clinical Trials

10 trials of TMS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed. 10 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 210Completed 10
Phase 12Completed 2
Phase 32Completed 2

Follow TMS: new trials by email Literature Review of TMS trials Research Report on TMS

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Individualized Functional Connectivity Targeting in aiTBS for Depression
transcranial magnetic stimulation - Depressive Disorder, Major, Depression
Phase 2CompletedBrigham and Women's Hospital402023-07-152026-08-25
Symptom-specific TMS Targets for Depression and Anxiety
Transcranial magnetic stimulation - Depression, Anxiety
Phase 2CompletedBrigham and Women's Hospital402021-02-032024-08-01
Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial
Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet, Telmisartan 40Mg Oral Tablet, Atorvastatin 20 Mg Oral Tablet - COVID-19, COVID-19 Drug Treatment
Phase 2 / Phase 3CompletedANRS, Emerging Infectious Diseases2942020-11-272024-12-27
RTMS for Treatment of Pain and Craving
Real Transcranial Magnetic Stimulation, Sham Transcranial Magnetic Stimulation - Pain, Chronic, Pain Acute
Phase 2CompletedMedical University of South Carolina222017-07-062024-09-19
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Rituximab, Conditioning chemotherapy, TMS - Myelodysplastic Syndromes, Hodgkin's Lymphoma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)342015-09-242025-09-30
Evaluation of the H-Coil Transcranial Magnetic Stimulation(TMS) Device- Augmentation for Drug Resistant Depression
TMS - Major Depression
Phase 2CompletedBeerYaakov Mental Health Center402008-01-012009-10-06
Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Rituximab, Cyclosporine, Allogenic stem cell transplant (ASCT) - Myelodysplastic Syndrome, Hodgkin's Lymphoma
Phase 1 / Phase 2CompletedNational Cancer Institute (NCI)922007-10-302019-03-05
Repetitive Transcranial Magnetic Stimulation in Postpartum Depression
repetitive transcranial magnetic stimulation (rTMS) - Depression, Postpartum
Phase 2CompletedUniversity of Sao Paulo General Hospital142007-08-012011-10-14
Magnetic Brain Stimulation for the Treatment of Adult Depression
Prefrontal rTMS, Antidepressant Regimen, Sham Stimulation - Depression
Phase 2 / Phase 3CompletedMedical University of South Carolina1902005-02-012018-12-28
Efficacy of Repetitive Transcranial Magnetic Stimulation (rTMS) as an add-on Treatment for Resistant OCD
repetitive transcranial magnetic stimulation (rTMS) - Obsessive-Compulsive Disorder
Phase 2CompletedUniversity of Sao Paulo General Hospital302003-08-012010-01-07

Conditions studied

Depression (3)  ·  Depressive Disorder, Major (3)  ·  Hodgkin Disease (2)  ·  Leukemia (2)  ·  Lymphoma (2)  ·  Multiple Myeloma (2)  ·  Myelodysplastic Syndromes (2)  ·  Acute Pain (1)  ·  Anxiety Disorders (1)  ·  COVID-19 (1)  ·  Chronic Pain (1)  ·  Depression, Postpartum (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Mental Disorders (1)  ·  Mood Disorders (1)

Sponsors

Brigham and Women's Hospital (2)  ·  Medical University of South Carolina (2)  ·  National Cancer Institute (NCI) (2)  ·  University of Sao Paulo General Hospital (2)  ·  ANRS, Emerging Infectious Diseases (1)  ·  BeerYaakov Mental Health Center (1)

Countries

United States (6)  ·  Brazil (1)  ·  Côte d’Ivoire (1)  ·  Israel (1)

Top investigators

Alain Mina, M.D. (1)  ·  Carlos G Mansur, MD (1)  ·  Colleen A Hanlon, PhD (1)  ·  Joseph J Taylor, MD, PhD (1)  ·  Mark S. George, MD (1)  ·  Martin L Myczkowski, MSD (1)  ·  Oded Rosenberg, M.D. (1)  ·  Shan H Siddiqi, MD (1)  ·  Steven Z Pavletic, M.D. (1)

Results publications

PMID 20439832, PMID 21557884, PMID 23769413, PMID 32785680, PMID 38669315, PMID 39443527, PMID 40331908, PMID 41912790, PMID 42340706

NIH funding

R01MH069887 (1)